Trial Profile
Phase II Trial of FOLFOXIRI + Bevacizumab in Patients With Untreated Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Irinotecan; Levofolinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- Acronyms BeTRI
- 20 Mar 2020 Status changed from active, no longer recruiting to completed.
- 25 Jan 2020 Results (n=44) presented at the 2020 Gastrointestinal Cancers Symposium.
- 03 Apr 2019 Planned End Date changed from 1 Sep 2018 to 1 May 2019.